HomeNewsBusinessCashew nut consumption in India soars, making up for a decline in exports

Cashew nut consumption in India soars, making up for a decline in exports

People embracing a plant-based vegan diet prioritize alternative sources of protein, instead of those derived from animals, resulting in soaring demand for nuts and nut-infused foods.

July 01, 2022 / 16:34 IST
Story continues below Advertisement

Indians are munching more cashew nuts than ever before,    compelling manufacturers and processors to shift their focus to the domestic market from shrinking exports.

India has been the biggest consumer of cashew in the last few years, but consumption had taken a beating when COVID-19 hit the world in 2020. As lockdowns were lifted and the economy stabilized, people turned more to health foods, which included nuts as well, to develop immunity.

Story continues below Advertisement

The booming domestic market has galvanized the cashew processing industry, hitherto confined to southern states, to expand to other parts of the country.

Consumption in India is over 300,000 tonnes a year, said Pankaj M Sampat, director of Mumbai-based Samson Traders. It had been hovering around 200,000 tonnes before the pandemic.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show